Abiopharma

Planet Announces Redemption of Public Warrants

SafeSpace Global to Attend NIC Spring Conference to Engage Senior Living and Healthcare Leaders

Dingdong (Cayman) Limited Announces Results of 2026 Annual General Meeting

Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures

Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update

SB Financial Group, Inc. Announces Schedule for First Quarter 2026 Results

Lebrikizumab delivered long-term disease control for up to four years in patients with moderate-to-severe atopic dermatitis

First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement

Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics

United-Guardian Reports 2025 Financial Results